Saturday, July 11, 2026

pharma · Atrial Fibrillation

Advanz Pharma

Advanz Pharma clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

London, GB HQ
731 Employees
EMA registrant Type
Company details
Status
Public
HQ
London, GB
Employees
731
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Advanz Pharma projects

1 ClinicalTrials.gov programs sponsored by Advanz Pharma.

Advanz Pharma has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Placebo

    Advanz Pharma Limited

    Atrial Fibrillation

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Advanz Pharma have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.